Dasatinib and Low Intensity Chemotherapy for Ph+ Acute Lymphoblastic Leukemia

Clinical trial NCT02888990 · COMPLETED

Trial details

NCT number: NCT02888990
Sponsor: Versailles Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Leukemia, Lymphoblastic, Acute

Start date: 2007-08-01
Primary completion: 2011-05-01
Enrollment: 71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.